TrianglePUBLICATIONS · 22357255
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2012 Jul
- First author
- Reichardt P
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Reichardt P
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Gelderblom H
- type
- Author
- name
- Schlemmer M
- type
- Author
- name
- Demetri GD
- type
- Author
- name
- Bui-Nguyen B
- type
- Author
- name
- McArthur GA
- type
- Author
- name
- Yazji S
- type
- Author
- name
- Hsu Y
- type
- Author
- name
- Galetic I
- type
- Author
- name
- Rutkowski P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Reichardt P
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Gelderblom H
- type
- Author
- name
- Schlemmer M
- type
- Author
- name
- Demetri GD
- type
- Author
- name
- Bui-Nguyen B
- type
- Author
- name
- McArthur GA
- type
- Author
- name
- Yazji S
- type
- Author
- name
- Hsu Y
- type
- Author
- name
- Galetic I
- type
- Author
- name
- Rutkowski P
- type
- Author
- bibliography ids
- nci-bib-c0d7ff8e6a1e63d82bede471
- book metadata
- content sha256
- 36e33d4835a4cb65a055def238c9ad855b73d28e479dfb023c9f229da24b3a0a
- document type
- citation
- dois
- 10.1093/annonc/mdr598
- electronic publication date
- display
- 2012 Feb 21
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22357255
- immutable id
- pubmed:22357255@36e33d4835a4cb65a055def238c9ad855b73d28e479dfb023c9f229da24b3a0a
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 7
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 1680-7
- volume
- 23
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22357255
- provenance
- batch id
- b6284687e167e7da9556
- provider
- NCBI PubMed ESummary
- record sha256
- e6d06eea0476088e4bd8541c9a4b7e90c63998fb2b59cb9208277edc5449095f
- response sha256
- 64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
- retrieved at
- 2026-09-09T23:46:45.216259+00:00
- publication date
- display
- 2012 Jul
- precision
- month
- year
- 2012
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.
Preserved source evidence · Not medical advice